We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

96 hedge funds and large institutions have $672M invested in La Jolla Pharmaceutical Company in 2017 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

557% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 7

141% more capital invested

Capital invested by funds: $279M → $672M (+$393M)

55% more funds holding

Funds holding: 62 → 96 (+34)

41% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 17

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

0% more call options, than puts

Call options by funds: $8.45M | Put options by funds: $8.43M

Holders
96
Holders Change
+34
Holders Change %
+54.84%
% of All Funds
2.39%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
46
Increased
24
Reduced
17
Closed
7
Calls
$8.45M
Puts
$8.43M
Net Calls
+$26K
Net Calls Change
-$2.44M

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$38.6M
2
CCM
Consonance Capital Management
New York
+$36.3M
3
BlackRock
BlackRock
New York
+$23.3M
4
PA
Perceptive Advisors
New York
+$20.9M
5
RG
Redmile Group
California
+$15.4M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$18.6M
2
JHIU
Janus Henderson Investors US
Colorado
-$6.11M
3
SM
Sabby Management
Florida
-$5.39M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$3.77M
5
Franklin Resources
Franklin Resources
California
-$3.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$3.28M +$118K +4,611 +4%
MIM
27
Monashee Investment Management
Massachusetts
$2.98M – – –
LP
28
LMR Partners
United Kingdom
$2.39M +$2.04M +80,000 New
SAM
29
Sectoral Asset Management
Quebec, Canada
$2.35M +$2.01M +78,700 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.27M +$118K +4,619 +6%
Alyeska Investment Group
31
Alyeska Investment Group
Illinois
$2.24M +$1.91M +75,000 New
HCMT
32
Highland Capital Management (Texas)
Texas
$2.19M +$1.88M +73,500 New
TAM
33
Tocqueville Asset Management
New York
$2.09M +$512K +20,050 +40%
Morgan Stanley
34
Morgan Stanley
New York
$1.94M -$2.38M -93,342 -59%
Deutsche Bank
35
Deutsche Bank
Germany
$1.74M +$516K +20,219 +53%
AI
36
Axiom Investors
Connecticut
$1.59M +$1.36M +53,190 New
VKH
37
Virtu KCG Holdings
New York
$1.26M +$1.08M +42,331 New
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$1.26M +$128K +5,000 +13%
AAM
39
Advisors Asset Management
Colorado
$1.09M -$98K -3,839 -10%
TCIM
40
TIAA CREF Investment Management
New York
$1.08M -$64.2K -2,516 -6%
LCM
41
Laurion Capital Management
New York
$1.04M +$894K +35,000 New
FO
42
FT Options
Illinois
$989K +$846K +33,141 New
ICM
43
ISZO Capital Management
New York
$924K +$791K +30,967 New
Swiss National Bank
44
Swiss National Bank
Switzerland
$878K +$128K +5,000 +20%
Tudor Investment Corp
45
Tudor Investment Corp
Connecticut
$857K +$733K +28,720 New
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$818K -$33.2K -1,300 -5%
EI
47
EAM Investors
California
$786K +$672K +26,323 New
TA
48
Teachers Advisors
New York
$758K – – –
Goldman Sachs
49
Goldman Sachs
New York
$731K +$625K +24,482 New
HI
50
HBK Investments
Texas
$672K +$574K +22,500 New
1
2
3 4 5

LJPC Hedge Fund Activity: Q1 2017 in Review

96 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q1 2017, worth a combined $672M — up 141% from $279M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new LJPC positions and 7 closed out — a net gain of 39 holders — while 24 added to existing stakes and 17 trimmed.

The largest buyer was Jennison Associates, adding an estimated $38.6M. The largest seller was Broadfin Capital, cutting an estimated $18.6M.

  • 96 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q1 2017, up from 62 in Q4 2016.
  • Funds reported $672M of La Jolla Pharmaceutical Company stock for Q1 2017, up 141% quarter-over-quarter.
  • 46 funds opened new La Jolla Pharmaceutical Company positions in Q1 2017 and 7 closed out, a net change of +39 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q1 2017 was Jennison Associates, an estimated $38.6M added.
  • The largest La Jolla Pharmaceutical Company seller in Q1 2017 was Broadfin Capital, an estimated $18.6M sold.

Based on aggregated 13F filings for Q1 2017.